Improving the efficacy of preoperative autologous blood donation in patients with low hematocrit: A randomized, double-blind, controlled trial of recombinant human erythropoietin

American Journal of Medicine

Volumn 101, Issue 2 A, 1996, Pages 22S-27S

  Price, Thomas H ^a,g   Goodnough, Lawrence T ^b   Vogler, William R ^c   Sacher, Ronald A ^d   Hellman, Richard M ^e   Johnston, Marilyn F M ^b   Bolgiano, Douglas C ^a   Abels, Robert I ^f  

^a UNIVERSITY OF WASHINGTON   (United States)

^b S LOUIS UNIV HLTH SCIENCES CENTER   (United States)

^c Atlanta Cancer Care   (United States)

^d GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^e Lawrence and Memorial Hospital   (United States)

^f R W JOHNSON PHARMACEUTICAL RES I   (United States)

^g PUGET SOUND BLOOD CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ANEMIA; BLOOD AUTOTRANSFUSION; BLOOD DONOR; CLINICAL PROTOCOL; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HEMATOCRIT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; NAUSEA; ORTHOPEDIC SURGERY; PHLEBOTOMY; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VERTIGO; ARTICLE; ELECTIVE SURGERY; MIDDLE AGED; MULTICENTER STUDY; ORTHOPEDICS; PREOPERATIVE CARE; RISK; STATISTICAL MODEL; TREATMENT OUTCOME;

AGED; BLOOD DONORS; BLOOD TRANSFUSION, AUTOLOGOUS; DOUBLE-BLIND METHOD; EPOETIN ALFA; FEMALE; HEMATOCRIT; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ORTHOPEDICS; PREOPERATIVE CARE; RISK; SURGICAL PROCEDURES, ELECTIVE; TREATMENT OUTCOME;

EID: 0030602926     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9343(96)00165-9     Document Type: Conference Paper

References (26)

1. Toy PT, Strauss RG, Stehling LC, et al. Predeposited autologous blood for elective surgery. A national multicenter study. N Engl J Med. 1987;316:517-520.
2. Wallace EL, Surgenor DM, Hao HS, et al. Collection and transfusion of blood and blood components in the United States, 1989. Transfusion. 1993;33:139-144.
3. Love TR, Hendren WG, O'Keefe DD, Daggett WM. Transfusion of predonated autologous blood in elective cardiac surgery. Ann Thorac Surg. 1987;43:508-512.
4. Britton LW, Eastlund DT, Dziuban SW, et al. Predonated autologous blood use in elective cardiac surgery. Ann Thorac Surg. 1989;47:529-532.
5. Owings DV, Kruskall MS, Thurer RL, Donovan LM. Autologous blood donations prior to elective cardiac surgery. Safety and effect on subsequent blood use. JAMA. 1989;262:1963-1968.
6. Goodnough LT, Shafron D, Marcus RE. The impact of preoperative autologous blood donation on orthopaedic surgical practice. Vox Sang. 1990;59:65-69.
7. Zussa C, Polesel E, Salvador L, et al. Efficacy and safety of predeposit blood autodonation in 500 cases of myocardial revascularization. Scand J Thorac Cardiovasc Surg. 1990;24:171-175.
8. Goldfinger D, Capon S, Czer L, et al. Safety and efficacy of preoperative donation of blood for autologous use by patients with end-stage heart or lung disease who are awaiting organ transplantation. Transfusion. 1993;33:336-340.
9. Kruskall MS, Glazer EE, Leonard SS, et al. Utilization and effectiveness of a hospital autologous preoperative blood donor program. Transfusion. 1986;26:335-340.
10. Goodnough LT, Wasman J, Corlucci K, Chernosky A. Limitations to donating adequate autologous blood prior to elective orthopedic surgery. Arch Surg. 1989;124:494-496.
11. Goodnough LT, Brittenham GM. Limitations of the erythropoietic response to serial phlebotomy: implications for autologous blood donor programs. J Lab Clin Med. 1990;115:28-35.
12. Kickler TS, Spivak JL. Effect of repeated whole blood donations on serum immunoreactive erythropoietin levels in autologous donors. JAMA. 1988;260:65-67.
13. Lorentz A, Eckardt KU, Osswald PM, Duchow JR. Erythropoietin levels in patients depositing autologous blood in short intervals. Ann Hematol. 1992;64:281-285.
14. Goodnough LT, Rudnick S, Price TH, et al. Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy. N Engl J Med. 1989;321:1163-1168.
15. Thompson FL, Powers JS, Graber SE, Krantz SB. Use of recombinant human erythropoietin to enhance autologous blood donation in a patient with multiple red cell allo-antibodies and the anemia of chronic disease. Am J Med. 1991;90:398-400.
16. Watanabe Y, Fuse K, Naruse Y, et al. Subcutaneous use of erythropoietin in heart surgery. Ann Thorac Surg. 1992;54:479-484.
17. Kulier AH, Gombotz H, Fuchs G, et al. Subcutaneous recombinant human erythropoietin and autologous blood donation before coronary artery bypass surgery. Anesth Analg. 1993;76:102-106.
18. Mercuriali F, Zanella A, Barosi G, et al. Use of erythropoietin to increase the volume of autologous blood donated by orthopedic patients. Transfusion. 1993;33:55-60.
19. Goodnough LT, Price TH, Friedman KD, et al. A phase III trial of recombinant human erythropoietin therapy in nonanemic orthopedic patients subjected to aggressive removal of blood for autologous use: dose, response, toxicity, and efficacy. Transfusion. 1994;34:66-71.
20. Beris P, Mermillod B, Levy G, et al. Recombinant human erythropoietin as adjuvant treatment for autologous blood donation. A prospective study. Vox Sang. 1993;65:212-218.
21. Hayashi J, Kumon K, Takanashi S, et al. Subcutaneous administration of recombinant human erythropoietin before cardiac surgery: a double-blind, multicenter trial in Japan. Transfusion. 1994;34:142-146.
22. Goodnough LT, Price TH, Rudnick S, Soegiarso RW. Preoperative red cell production in patients undergoing aggressive autologous blood phlebotomy with and without erythropoietin therapy. Transfusion. 1992;32:441-445.
23. Tasaki T, Ohto H, Hashimoto C, et al. Recombinant human erythropoietin for autologous blood donation: effects on perioperative red-blood-cell and serum erythropoietin production. Lancet. 1992;339:773-775.
24. Mercuriali F, Gualtieri G, Sinigaglia L, et al. Use of recombinant human erythropoietin to assist autologous blood donation by anemic rheumatoid arthritis patients undergoing major orthopedic surgery. Transfusion. 1994;34:501-506.
25. Biesma DH, Marx JJ, Kraaijenhagen RJ, et al. Lower homologous blood requirement in autologous blood donors after treatment with recombinant human erythropoietin. Lancet. 1994;344:367-370.
26. Price TH, Goodnough LT, Vogler WR, et al. The effect of recombinant human erythropoietin on the efficacy of autologous blood donation in patients with low hematocrits: a multicenter, randomized, double-blind, controlled trial. Transfusion. 1996;36:29-36.